<DOC>
	<DOCNO>NCT02883647</DOCNO>
	<brief_summary>The study observe therapeutic effect long-term follow-up end anti-HBV therapy nucleos ( ) ide analogs patient chronic hepatitis b .</brief_summary>
	<brief_title>Therapeutic Effects Long-term Follow-up After Ending Nucleos ( ) Ide Analogs Therapy Chronic Hepatitis b</brief_title>
	<detailed_description>Patients chronic hepatitis b enrol study . Age , sex , weight , height , symptom ( e.g. , fatigue , poor appetite , jaundice ) , relapse , retreatment , occurrence liver cirrhosis hepatocellular carcinoma ( HCC ) , mortality survival rate record study . We also observe laboratory test include level white blood cell ( WBC ) , red blood cell ( RBC ) , hemoglobin ( HGB ) , platelet ( PLT ) , alanine transaminase ( ALT ) , aspartate transaminase ( AST ) , total bilirubin ( TBIL ) , blood urea nitrogen ( BUN ) , creatine , hepatitis B surface antigen ( HBsAg ) , hepatitis B e antigen ( HBeAg ) , hepatitis B virus ( HBV ) DNA , CD4 positive T lymphocyte ( CD4+T ) , CD8 positive T lymphocyte ( CD8+T ) , Type 1 helper T lymphocyte ( Th1 ) , Type 2 helper T lymphocyte ( Th2 ) , fibroscan B ultrasound . If clinical relapse occur , patient retreat nucleos ( ) ide analog .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>1 . Patients receive antiHBV therapy nucleos ( ) ide analog . 2 . Last antiHBV therapy continue least 2 year . 3 . For HBeAg positive patient , HBV DNA keep negative least 1 year HBeAg seroconversion therapy end ; HBeAg negative patient , HBV DNA keep negative least 2 year therapy end . 1 . Liver cirrhosis , HCC ; 2 . Patients factor cause active liver disease ; 3 . Pregnancy lactation ; 4 . Patients HIV infection congenital immune deficiency disease ; 5 . Patients severe diabetes , autoimmune disease , important organ dysfunction serious complication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>chronic hepatitis b , nucleos ( ) ide analog</keyword>
</DOC>